1 / 22

Clinical Quality Indicators – Martin Orton

Clinical Quality Indicators – Martin Orton. Background. IC changing to support front line services New clinical focus with new Medical Director – Dr Mark Davies General desire to measure outcomes, not just activity Next Stage (Darzi) Review – focus on Quality.

manju
Download Presentation

Clinical Quality Indicators – Martin Orton

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Quality Indicators – Martin Orton

  2. Background • IC changing to support front line services • New clinical focus with new Medical Director – Dr Mark Davies • General desire to measure outcomes, not just activity • Next Stage (Darzi) Review – focus on Quality

  3. High Quality Care for All Measuring Quality • The next stage in achieving high quality care, requires us to unlock local innovation and improvement of quality through information – information which shows clinical teams where they most need to improve, and which enables them to track the effect of changes they implement. After all, we can only be sure to improve what we can actually measure. 10. It is important that we have a national quality framework that enables us to publish comparable information on key measures. With the help and support of frontline clinicians, we have begun to identify comparable measures that are currently used by different parts of the service today, and will bring them together into an integrated national set. These national metrics will be developed through discussion with patients, the public and staff. We will announce the first set of quality indicators that will be used nationally by December 2008. And although we will begin with acute services, from next year, we will also develop and pilot a quality framework for community services. 11. The national metrics will be important, but it will be critical that local NHS organisations should sign up to the concept of quality metrics and feel motivated to augment the national indicators with their own measurements of quality. Our aim is for NHS organisations to freely develop the measures that will best help them to review the quality of the services they offer regularly. (p 50)

  4. Darzi definition of Quality • Patient safety • Safe & Clean • Minimising avoidable harm (e.g drug errors, HAI) • Patient experience • Compassion, dignity & respect • Patient satisfaction • Effectiveness of care • Survival rates • Complication rates • Measures of clinical improvement • PROMs

  5. Level 4: National priorities for improvement 4 Mandatory data collection Level 3 Level 2: National standard definitions Level 1: Locally-defined metrics for local use Levels and Uses of Indicators We think there will be four levels of metrics, which range from the key national priorities (e.g. HCAI) to local defined and locally collected metrics.

  6. Objectives Primary Objective: • To develop a first set of indicators (“Phase 1”) of clinical quality and outcome covering major NHS acute services, which will be available for use in FY 2009/10. The indicators’ primary use will be to guide quality improvement through comparison and benchmarking, to facilitate local improvement efforts. Secondary Objectives: • To use the launch of the first set of indicators to signal the intention to stimulate clinical stakeholders and the local NHS to develop better and more discriminating indicators over subsequent years (“Phase 2”) • To identify well-defined indicators for which data collection is not fully complete, for potential incentivisation of data collection under CQUIN during 2009/10 (to allow use in 2010/11) • Potential source in future for public-facing data e.g. “Quality Accounts”, perhaps some indicators carried over to NHS Choices etc. • NOT for targets or traditional “performance management”

  7. Clinical Quality Indicators • Phase 1 • Best that can be produced with current data & information for 09/10 – recognised as limited • Driven by Darzi & Keogh to show direction of travel • Phase 2 • Clinically driven, meaningful measures of clinical quality for local, regional & national use • Blank canvas • Will involve co-ordinated working within clinicians, prof bodies, DH, CQC, NICE, CFH, NCAAG and others

  8. CQI Governance • Expected to come under the new Quality Board • IC commissioned by DH Medical Director, Prof. Sir Bruce Keogh

  9. Phase 1 • Focus on acute (Primary care already has QOF, gaps in community and social care) • Also Mental Health & Ambulance • Must be measurable in 2009 • Recognise indicators will have limitations • DH gone for lots, rather than a few which could draw excessive focus and distort services

  10. Phase 1 Indicators Gantt Response from Medical & Nursing Dirs re BK letter NHS consultation on proposed indicators Create 1st draft indicators list June Review responses and agree indicators Aug Sept Jul Publish indicator list for 09/10 Oct Nov Implement indicator tool Dec Jan Feb Mar

  11. Phase 1 Categories Approx 400 indicators across 13 categories • Cancer (42 indicators) • Cardiovascular (59 indicators) • Children, Families and Maternity (9 indicators) • Healthcare Acquired Infections (37 indicators) • Long Term Conditions (23 indicators) • Mental Health (15 indicators) • Mortality (65 indicators) • Patient Experience (92 indicators) • Patient Reported Outcome Measures (4 indicators) • Patient Safety (35 indicators) • Readmissions (31 indicators) • Revisions (17 indicators) • Timeliness (7 indicators)

  12. Phase 2 • Consultation with phase 1 – to ensure clinicians know this follows phase 1 • To test ideas, and find out about existing work & clinician’s ideas • Aim to set-up work this FY to start next FY

  13. Phase 2 • Clinically driven • IC to lead the programme • Working with Clinicians, Prof. bodies, CQC, DH, CFH, NICE, NCAAG, Patient groups • Blank canvas, but using existing work and ideas where available

  14. Phase 2 (cont.) Potential methodologies • Better use of existing data (HES, QOF, Audit, etc) • Extending PROMs (further surgical procedures, long term conditions) • New audits / Specific treatment data & information (German model) • Clinical assessment schemes • Pathways, outcomes & some process measures

  15. Patient Reported Outcome Measures PROMs • 4 surgical procedures from April 09 • Hip & knee replacements, varicose veins and groin hernias • Pre & post op questionnaires • Treatment specific & Quality of Life • Give measure of health gain • Various outcomes (after casemix adjustment) • Thresholds for treatment • Different treatment comparisons • Unit/clinician comparisons • etc

  16. Lot 2: “Aggregation” Lot 1: “Administration” Information Centre: “Linkage” & “Repository” NJR SUS Other Develop adjustment Pre-op Linked Pseud’sed identifiable IC Case-mix adjustment Post-op Aggregation Scoring, outcomes Extract Service Lot 3: “Analysis” Record level data Aggregated data Academic stakeholders Healthcare stakeholders Record-level data PROMs contractual model Aggregated data

  17. PROMs timescales • MOI out now for OJEU tenders • SLA for IC work Oct-08 • Contracts by Dec-08 • Needs to be running for April-09 • Real data flows from Summer-09 (pre & post op pairs) – 20k per month • Outcome outputs in 2010?

  18. Supplier Opportunities • Phase 1 Clinical Quality Indicators presentation system likely to be outsourced • Clinical Quality Indicators available through syndication

  19. QUESTIONS ?

  20. Notes: • Overall process operated and owned by IC • Processes transparent, auditable and conform to care record guarantee Tier 1 Tier 2 Tier 3 Services Operated by IC Services Operated by Commercial Providers Workforce Data (+ESR) Base Information presentation Managing input from NHS Sources Finance Data Data Presentation NHS Spine Data (PDS) (but could be PSIS, Medication Record Etc) SYNDICATION HONEST BROKER APPROVALS SIGN POSTING SUS Database Value Added Information Services Research Data Other Data Sources Research Services IC Data & Information Future Access Model

  21. Linked HES, PROMs & NJR data Workforce Data (+ESR) Finance Data Data Presentation SUS Database Value Added Information Services Research Data Other Data Sources Research Services PROMs IC Functions Casemix adjust & analysis Base information presentation PROMs data Data linkage IC overview and standards development Tier 1 Tier 2 Tier 3 Services Operated by IC Services Operated by Commercial Providers Base Information presentation e.g. Perf. Benchmarking (SIFTER) NHS Comparators Managing input from NHS Sources NHS Spine Data (PDS) (but could be PSIS, Medication Record Etc) SYNDICATION HONEST BROKER APPROVALS SIGN POSTING • Notes: • Overall process operated and owned by IC • IT Systems in Tiers 1 and 2 Procured and suppliers managed by NHS CFH • Processes transparent, auditable and conform to care record guarantee

More Related